Compare MYE & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYE | SDGR |
|---|---|---|
| Founded | 1933 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 825.9M | 925.8M |
| IPO Year | 1995 | 2020 |
| Metric | MYE | SDGR |
|---|---|---|
| Price | $22.87 | $15.15 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 9 |
| Target Price | ★ $26.00 | $21.00 |
| AVG Volume (30 Days) | 207.7K | ★ 1.2M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.71% | N/A |
| EPS Growth | ★ 389.47 | 45.14 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $255,869,000.00 |
| Revenue This Year | $0.87 | $0.76 |
| Revenue Next Year | $1.83 | $4.60 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 23.29 |
| 52 Week Low | $12.29 | $10.95 |
| 52 Week High | $24.25 | $27.63 |
| Indicator | MYE | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 56.31 | 73.89 |
| Support Level | $20.03 | $11.27 |
| Resistance Level | $23.14 | $19.51 |
| Average True Range (ATR) | 0.81 | 0.71 |
| MACD | 0.09 | 0.22 |
| Stochastic Oscillator | 65.60 | 91.87 |
Myers Industries Inc designs, manufactures, and markets a variety of plastic, metal, and rubber products, including a broad selection of plastic reusable containers, pallets, small parts bins, bulk shipping containers, storage and organization products, OEM parts, custom plastic products, consumer fuel containers and tanks for water, fuel and waste handling. It operates through the following segments: The Material Handling segment manufactures a selection of durable plastic reusable products that are used repeatedly during the course of their service life. The Distribution segment is engaged in the distribution of equipment, tools, and supplies used for tire servicing and automotive under-vehicle repair, etc. It generates the majority of its revenue from the Material Handling segment.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.